News | May 09, 2026
Lonza surges on biologics boom
Expands manufacturing push & locks in major growth deals
Expands manufacturing push & locks in major growth deals
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
Growth was broad-based across segments
Pharma giant targets new standards of care
By cutting pain crises & boosting haemoglobin
Revvity is positioning its technologies as a connected engine for discovery
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
Beyond clinical trials, real-world evidence is adding weight to AbbVie’s claims
CagriSema produced a 23% weight loss at 84 weeks, versus 25.5% for tirzepatide
Subscribe To Our Newsletter & Stay Updated
